Cargando…
Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
Increases in antibiotic usage and antimicrobial resistance occurrence have caused a dramatic reduction in the effectiveness of many frontline antimicrobial treatments. Topoisomerase inhibitors including fluoroquinolones are broad-spectrum antibiotics used to treat a range of infections, which stabil...
Autores principales: | Grossman, Scott, Fishwick, Colin W. G., McPhillie, Martin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964621/ https://www.ncbi.nlm.nih.gov/pubmed/37259406 http://dx.doi.org/10.3390/ph16020261 |
Ejemplares similares
-
Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
por: Dauda, Soziema E., et al.
Publicado: (2023) -
Activities of gyrase and topoisomerase IV on positively supercoiled DNA
por: Ashley, Rachel E., et al.
Publicado: (2017) -
Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization
por: Hsu, Ya-Han, et al.
Publicado: (2006) -
De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region
por: Orritt, Kyle M., et al.
Publicado: (2022) -
The Structural
Features of Novel Bacterial Topoisomerase
Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)